Usc /Id# 164235 — Los Angeles, California

Usc /Id# 164235 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Usc /Id# 164235 has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma Multiforme.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Usc /Id# 164235?

Usc /Id# 164235 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Usc /Id# 164235 conducted?

Usc /Id# 164235 has 1 clinical trials on record. Their work covers Glioblastoma Multiforme.

Is Usc /Id# 164235 accredited by Crixeo Health?

Usc /Id# 164235 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Usc /Id# 164235?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.